The investigational RNA interference therapeutic, zilebesiran, has shown positive top-line results in the KARDIA-2 phase 2 study for the treatment of hypertension when added to standard-of-care […]
FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone events in cancer 3/05/2024 Jubbonti and Wyost Denosumab-bbdz […]
Speech by Robert M. Califf, M.D., MACC (Remarks as prepared for delivery) Good morning. I’m delighted to be with you today and support your efforts to […]
Subscribe for email updates Recommended Acceptable Intake (AI) Limits and Testing Methods On 8/4/2023, FDA issued a final guidance on Recommended Acceptable Intake Limits for Nitrosamine […]
The following are common questions and answers about supply chain security requirements of the Drug Supply Chain Security Act. 1. Is the pedigree provision of the […]
WEST PALM BEACH, Florida — Nearly 70% of patients with relapsing multiple sclerosis (RMS) were free from relapse after 5 years of treatment with ozanimod (Zeposia), […]
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Jennifer C. Ellis Recipient Title President and CEO Cosmetic Specialty Labs, Inc. 210 SW Texas Ave.Lawton, […]
Delivery Method: UPS Next Day Product: Drugs Recipient: Recipient Name Mr. Mohammed Saremi Recipient Title Chief Executive Officer Bell International Laboratories, Inc. 2950 Lexington Ave. S., […]
Product: Drugs Recipient: ivsupplyclinic.com United States Issuing Office: Center for Drug Evaluation and Research | CDER United States Secondary Issuing Offices United States FROM: The United […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.